University of Amsterdam

The University of Amsterdam (UvA) is one of the Netherlands' leading research universities, with its Amsterdam UMC Department of Psychiatry conducting clinical trials on psilocybin and psychedelic-assisted therapies for treatment-resistant mental health conditions.

University of Amsterdam

Academic Research

Quick Facts

Sponsored Trials

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression

Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence (PsiPTSD)

Drug Effects on Mood and Behavior – Expectancy (MESA-X)

Psilocybin for Prolonged Grief Disorder

Stress Experience Following Psilocybin (SEP-1)

Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

Treatment of Persistent Post-concussive Symptoms With Psilocybin Assisted Therapy (PatACT)

(GluEsk) Glutamate and Esketamine (GluEsk)

Psilocybin vs Ketamine for Alcohol Use Disorder (Psi vs Ket)

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder (PAP-AUD)

Effect of Psychedelic VR-augmented Therapy on Patients With Clinical Depression

Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers

Prosocial Effects of MDMA (PEM)

Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation

Metabolic Profiling of Esketamine Treatment in Depressive Disorder

Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout (PAPR)

Psilocybin-assisted Interpersonal and Social Rhythm Therapy for Depression

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Collaborated Trials

Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement

KF2024#1-trial: Esketamine Interaction Study

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)

Mood and Cognitive Effects of Psilocybin in Healthy Participants (MELO)

Ketamine in Acute Brain Injury Patients

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

The NeXT Study

Company

Product

Legal